Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-05

Clinical Trial Update: 52 Week Trial of Liraglutide in Type 1 Diabetes [Phase 4]

View source ↗

Summary

A completed Phase 4 trial update on liraglutide use in Type 1 diabetes with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2018-01-05